Author

Rafał Matkowski

Wroclaw Medical UniversityORCID 0000-0002-1705-5097Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Piotr KasprzakiD· 2 shared Alicja WoźnaiD· 1 shared Bartosz Dołęga-KozierowskiiD· 1 shared Boris TurkiD· 1 shared Jerzy Ł. WiśniewskiiD· 1 shared Julia NguyeniD· 1 shared M DabrowskiiD· 1 shared Maciej PiernikiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Piotr KasprzakORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Medicinal ChemistryPeer-reviewedJul 1, 2026

Engineering cathepsin S selective chemical probes and antibody-drug conjugates through substrate profiling with unnatural amino acids

Maria Łęcka, Oliwia Gorzeń, Natalia Ćwilichowska-Puślecka…·Marcin Poręba

The paper develops selective chemical probes and antibody-drug conjugates for cathepsin S by profiling substrate specificity with unnatural amino acids and validates their efficacy in cancer models.

2 citationstop 3%

humanproteomics

Genetic & Genomic MedicineMolecular Diagnosis & TherapyPeer-reviewedDec 21, 2021

Validation of HER2 status in whole genome sequencing data of breast cancers with AI-driven, ploidy-corrected approach

Marzena Liliana Wojtaszewska, Rafał Stępień, Alicja Woźna…·Paweł Zawadzki

The paper develops an AI-driven, ploidy-corrected method using whole genome sequencing to accurately determine HER2 status in breast cancer patients.

3 citations

humanwhole-genome sequencing